Main Article Content

Abstract

Highlights:
1. The increased incidence of placenta accreta is contributed significantly by parity classification, a history of cesarean section, body mass index, and interbirth interval.
2. The findings of this study can be used as an additional reference in determining the risk of placenta accreta in pregnant women, specifically as an input in screening and antenatal care programs for pregnant women to provide early detection and appropriate management.


 


Abstract


The incidence of placenta accreta during pregnancy constitutes a serious problem in reproductive health. This complication has increased significantly over the last few decades, especially in developed countries where cesarean deliveries have also risen. Placenta accreta spectrum can cause very severe bleeding and potentially lead to other serious complications. The purpose of this study was to analyze the risk factors associated with the incidence of placenta accreta in women giving birth at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia. This quantitative study used an analytical observational research design, specifically the case-control approach. The study sample was all mothers who gave birth at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia, between 2019 and 2023. In addition to a univariate analysis, the data were subjected to bivariate analysis using a two-sample independent t-test or Mann-Whitney test for ordinal data and for nominal data using the Chi-square test as well as multivariate analysis using logistic regression (p<0.05). The results showed that parity, a history of cesarean section, body mass index, and interbirth interval were the variables identified as significantly associated with placenta accreta. According to the logistic regression analysis, parity, a history of cesarean section, and a history of curettage were identified as the primary determinants of placenta accreta incidence. The classification of parity was found to have the most significant relationship to the incidence of placenta accreta. This study concluded that parity classification, a history of cesarean section, body mass index, and interbirth interval are the significant risk factors contributing to the increased incidence of placenta accreta at Dr. Soetomo General Academic Hospital, Surabaya, Indonesia.

Keywords

Reproductive health Pregnancy Maternal health Placenta accreta

Article Details

How to Cite
Aisha Grayli Cahyani, Willy Sandhika, & Gatut Hardianto. (2024). Analysis of Risk Factors Associated with the Incidence of Placenta Accreta at an Indonesian Tertiary Hospital. Folia Medica Indonesiana, 60(3), 224–231. https://doi.org/10.20473/fmi.v60i3.61214

References

  1. Antila-Långsjö RM, Mäenpää JU, Huhtala HS, et al (2018). Cesarean scar defect: A prospective study on risk factors. American Journal of Obstetrics and Gynecology 219, 458.e1-458.e8. doi: 10.1016/j.aj og.2018.09.004.
  2. Berlac JF, Hartwell D, Skovlund CW, et al (2017). Endometriosis increases the risk of obstetrical and neonatal complications. Acta Obstetricia et Gynecologica Scandinavica 96, 751–760. doi: 10.1111/aogs.13111.
  3. Bowman Z, Eller A, Bardsley T, et al (2013). Risk factors for placenta accreta: A large prospective cohort. American Journal of Perinatology 31, 799–804. doi: 10.1055/s-0033-1361833.
  4. Carusi DA, Gopal D, Cabral HJ, et al. (2023). A risk factor profile for placenta accreta spectrum in pregnancies conceived with assisted reproductive technology. F&S Reports 4, 279–285. doi: 10.1016/j.xfre.2023.05.004.
  5. Damayanti GV, Rachman IT, Trirahmanto A (2022). Outcome overview of placenta accreta spectrum patients undergoing conservative and non-conservative management at Dr. Sardjito General Hospital. Jurnal Kesehatan Reproduksi. doi: 10.22146/jkr.74838.
  6. Engelbrechtsen L, Langhoff‐Roos J, Kjer JJ, et al (2015). Placenta accreta: Adherent placenta due to a sherman syndrome. Clinical Case Reports 3, 175–178. doi: 10.1002/ccr3.194.
  7. Farquhar CM, Li Z, Lensen S, et al (2017). Incidence, risk factors and perinatal outcomes for placenta accreta in Australia and New Zealand: A case–control study. BMJ Open 7, e017713. doi: 10.1136/bmjopen-2017-017713.
  8. El Gelany S, Mosbeh MH, Ibrahim EM, et al (2019). Placenta Accreta Spectrum (PAS) disorders: Incidence, risk factors and outcomes of different management strategies in a tertiary referral hospital in Minia, Egypt: a prospective study. BMC Pregnancy and Childbirth 19, 313. doi: 10.1186/s12884-019-2466-5.
  9. IBM Corp. 2017. IBM SPSS statistics for Windows, Version 25.0. Armonk, NY: IBM Corp. Available at: https://www.ibm.com/support/pages/download ing-ibm-spss-statistics-25.
  10. Imafuku H, Tanimura K, Shi Y, et al (2021). Clinical factors associated with a placenta accreta spectrum. Placenta 112, 180–184. doi: 10.1016/j. placenta.2021.08.001.
  11. Irving FC, Herrtig AT (1937). A study of placenta acreta. Surgery Gynecology and Obstetrics 64, 178–200. Available at: https://sid.ir/paper/576120/ en.
  12. Jauniaux E, Alfirevic Z, Bhide A, et al (2019). Placenta praevia and placenta accreta: Diagnosis and management. BJOG: An International Journal of Obstetrics & Gynaecology. doi: 10.1111/1471-0528.15306.
  13. Jauniaux E, Jurkovic D, Hussein AM, et al (2022). New insights into the etiopathology of placenta accreta spectrum. American Journal of Obstetrics and Gynecology 227, 384–391. doi: 10.1016/j.ajog.2022.02.038.
  14. Kong X, Kong Y, Yan J, et al (2017). On opportunity for emergency cesarean hysterectomy and pregnancy outcomes of patients with placenta accreta. Medicine (Baltimore) 96, e7930. doi: 10.1097/MD.0000000000007930.
  15. Kyozuka H, Yamaguchi A, Suzuki D, et al (2019). Risk factors for placenta accreta spectrum: Findings from the Japan environment and Children’s study. BMC Pregnancy and Childbirth 19, 447. doi: 10.1186/s12884-019-2608-9.
  16. Li-Shu T, Yan H (2023). Establishment of decision tree prediction model for risk factors of placenta accreta spectrum disorders. Journal of Sichuan University (Medical Sciences) 54, 400–405. doi: 10.12182/20230260307.
  17. Li L, Liu L, Xu Y (2022). Hypertension in pregnancy as a risk factor for placenta accreta spectrum: A systematic review incorporating a network meta-analysis. Archives of Gynecology and Obstetrics 307, 1323–1329. doi: 10.1007/s004 04-022-06551-y.
  18. Matsuzaki S, Mandelbaum RS, Sangara RN, et al (2021). Trends, characteristics, and outcomes of placenta accreta spectrum: A national study in the United States. American Journal of Obstetrics and Gynecology 225, 534.e1-534.e38. doi: 10.1016/j.ajog.2021.04.233.
  19. McLaughlin HD, Benson AE, Scaglione MA, et al (2022). Association between short interpregnancy interval and placenta accreta spectrum. AJOG Global Reports 2, 100051. doi: 10.1016/j.xagr.2022.100051.
  20. Miller DA, Chollet JA, Goodwin TM (1997). Clinical risk factors for placenta previa–placenta accreta. American Journal of Obstetrics and Gynecology 177, 210–214. doi: 10.1016/S0002-9378(97)70463-0.
  21. Ming Y, Zeng X, Zheng T, et al (2022). Epidemiology of placenta accreta spectrum disorders in Chinese pregnant women: A multicenter hospital-based study. Placenta 126, 133–139. doi: 10.1016/j.placenta.2022.06.009.
  22. Mohammadi A, Bouzari Z, Hajian-Tilaki K, et al. (2022). Role of scaling combination of risk factors in clinical and imaging findings during pregnancy in predicting placenta accreta spectrum. Caspian Journal of Internal Medicine 13, 10–15. doi: 10.22088/cjim.13.1.10.
  23. Ornaghi S, Maraschini A, Donati S (2021). Characteristics and outcomes of pregnant women with placenta accreta spectrum in Italy: A prospective population-based cohort study ed. Petry CJ. PLoS One 16, e0252654. doi: 10.1371/journal.pone.0252654.
  24. Qatrunnada A, Agung Antonius P, Yusrawati Y (2018). Risk factors and outcomes of maternal placenta accreta at Dr. M. Djamil Padang General Hospital. Indonesian Journal of Obstetrics & Gynecology Science 1, 97–102. doi: 10.24198/obgynia.v1n2.94.
  25. Rac MWF, Dashe JS, Wells CE, et al (2015). Ultrasound predictors of placental invasion: The placenta accreta index. American Journal of Obstetrics and Gynecology 212, 343.e1-343.e7. doi: 10.1016/j.ajog.2014.10.022.
  26. Shaamash AH, AlQasem MH, Al Ghamdi DS, et al (2023). Adjunctive MRI in the diagnosis of placenta accreta spectrum in major placenta previa: Incidence, risk factors, and maternal morbidity. Annals of Saudi Medicine 43, 219–226. doi: 10.5144/0256-4947.2023.219.
  27. Sulistyono A (2021). Characteristics of mothers with placenta accreta at Dr. Soetomo Hospital, Surabaya, 2017-2019 (thesis). Universitas Airlangga. Available at: https://lib.unair.ac.id/ wplib/.
  28. Swarjana IK (2023). Health research methodology: Latest edition. Penerbit Andi, Yogyakarta. Available at: https://books.google.co.id/books/ab out/METODOLOGI_PENELITIAN_KESEHATAN.html?id=T7HJEAAAQBAJ&redir_esc=y.
  29. Tadayon M, Javadifar N, Dastoorpoor M, et al (2022). Frequency, risk factors, and pregnancy outcomes in cases with placenta accreta spectrum disorder: A case-control study. Journal of Reproduction & Infertility. doi: 10.18502/jri.v23i4 .10814.
  30. Weissgerber TL, Mudd LM (2015). Preeclampsia and diabetes. Current Diabetes Reports 15, 9. doi: 10.1007/s11892-015-0579-4.
  31. Zhao H, Li X, Yang S, et al (2023). Risk factors of emergency cesarean section in pregnant women with severe placenta accreta spectrum: A retrospective cohort study. Frontiers in Medicine. doi: 10.3389/fmed.2023.1195546.